JP2013537431A5 - - Google Patents

Download PDF

Info

Publication number
JP2013537431A5
JP2013537431A5 JP2013526038A JP2013526038A JP2013537431A5 JP 2013537431 A5 JP2013537431 A5 JP 2013537431A5 JP 2013526038 A JP2013526038 A JP 2013526038A JP 2013526038 A JP2013526038 A JP 2013526038A JP 2013537431 A5 JP2013537431 A5 JP 2013537431A5
Authority
JP
Japan
Prior art keywords
product according
spore
bacillus
symbiotic
probiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013526038A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013537431A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/048392 external-priority patent/WO2012027214A1/en
Publication of JP2013537431A publication Critical patent/JP2013537431A/ja
Publication of JP2013537431A5 publication Critical patent/JP2013537431A5/ja
Pending legal-status Critical Current

Links

JP2013526038A 2010-08-25 2011-08-19 シンバイオティクス製品 Pending JP2013537431A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37688810P 2010-08-25 2010-08-25
US61/376,888 2010-08-25
PCT/US2011/048392 WO2012027214A1 (en) 2010-08-25 2011-08-19 Synbiotic product

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017033618A Division JP2017113022A (ja) 2010-08-25 2017-02-24 シンバイオティクス製品

Publications (2)

Publication Number Publication Date
JP2013537431A JP2013537431A (ja) 2013-10-03
JP2013537431A5 true JP2013537431A5 (enExample) 2014-10-09

Family

ID=44533204

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013526038A Pending JP2013537431A (ja) 2010-08-25 2011-08-19 シンバイオティクス製品
JP2017033618A Withdrawn JP2017113022A (ja) 2010-08-25 2017-02-24 シンバイオティクス製品

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017033618A Withdrawn JP2017113022A (ja) 2010-08-25 2017-02-24 シンバイオティクス製品

Country Status (11)

Country Link
US (2) US9237763B2 (enExample)
EP (1) EP2608678A1 (enExample)
JP (2) JP2013537431A (enExample)
KR (1) KR20130102541A (enExample)
CN (2) CN103068254A (enExample)
AU (2) AU2011293625B2 (enExample)
BR (1) BR112013004194A2 (enExample)
CA (1) CA2808495A1 (enExample)
IL (1) IL224833A (enExample)
MX (1) MX348937B (enExample)
WO (1) WO2012027214A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010020639A1 (en) * 2008-08-18 2010-02-25 Bioactor Bvba Arabinoxylans for modulating the barrier function of the intestinal surface
US9125935B1 (en) 2011-05-31 2015-09-08 Nutech Ventures Probiotics and methods of obtaining same
CN104822277A (zh) * 2012-11-29 2015-08-05 雀巢产品技术援助有限公司 合生元组合物及其用途
PT2954041T (pt) 2013-02-06 2018-10-22 Envera Llc Misturas de composto germinativo de esporo secas
EP2769625A1 (en) * 2013-02-25 2014-08-27 Cargill, Incorporated Confectionery compositions
EP2769626A1 (en) * 2013-02-25 2014-08-27 Cargill, Incorporated Chewing gum composition
GB201312713D0 (en) * 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
BR112016008993B1 (pt) 2013-10-25 2021-08-31 Nch Corporation Composição probiótica para tratar animais, plantas, ou camas para animais, sistema para administrar uma composição probiótica, e, método para aumentar populações bacterianas benéficas nos tratos gastrointestinais de animais
US10766799B2 (en) 2014-05-23 2020-09-08 Nch Corporation Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
PE20170238A1 (es) 2014-05-23 2017-04-05 Nch Corp Metodo para la mejora de la calidad del agua de estanques para acuicultura
EP2805630A1 (en) * 2014-09-25 2014-11-26 Cargill, Incorporated Carbohydrate compositions
WO2017063909A1 (en) 2015-10-13 2017-04-20 Unilever N.V. A process for preparing metabolites by reaction of a prebiotic component with a probiotic component
CA3019732A1 (en) 2016-04-05 2017-10-12 Nch Corporation Nutrient rich germinant composition and spore incubation method
US10897922B2 (en) 2016-04-05 2021-01-26 Nch Corporation Composition and method for germinative compounds in probiotic food and beverage products for human consumption
US12097226B2 (en) 2016-04-05 2024-09-24 Nch Corporation System and method for using a single-serve nutrient spore composition for small scale farm applications
CN106689798B (zh) * 2016-11-17 2021-03-30 大连理工大学 海洋合生元添加剂及其制备方法与在刺参养殖中的应用
CN110582209A (zh) * 2017-04-10 2019-12-17 基博生物技术公司 用于消化系统健康,控制体重,增强免疫力和改善健康的多纤维益生元组合物
CN107198250B (zh) * 2017-05-23 2019-03-12 北京瑞千景科技发展有限公司 改善肠道微生态预防慢性病组合物和均衡营养食品及应用
WO2019147799A1 (en) 2018-01-24 2019-08-01 Omnigen Research, Llc Bacillus combination for administration to animals
EP3749106A1 (en) * 2018-02-06 2020-12-16 Sutherland, Duncan-Bruce Method of preparing prebiotic dietary fiber and probiotic-fibre complexes
US11401500B2 (en) 2018-08-29 2022-08-02 Nch Corporation System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
WO2020173963A1 (en) * 2019-02-25 2020-09-03 Servophil AG Deposition reduction
WO2021055492A1 (en) * 2019-09-16 2021-03-25 Microbiome Labs, Llc Spore-based probiotic supplementation in dogs and control of endotoxemia
WO2021159068A1 (en) 2020-02-06 2021-08-12 Nch Corportion Composition and method of using germinative compounds in probiotics for inflammation reduction in humans
US20230148645A1 (en) 2020-04-09 2023-05-18 Prabhakaran PANDURANGAN Therapeutic composition
CA3184420A1 (en) * 2020-06-30 2022-01-06 Mark C. Faulkner Compositions and methods for treatment of vaginal infections
CN112753988A (zh) * 2021-01-22 2021-05-07 上海沛藤生物工程有限公司 一种利用芽孢杆菌的小包装甜味剂及其制备方法
TR2022004759A2 (tr) * 2022-03-28 2022-04-21 Sayar Organik Biyolojik Ueruenler Imalat Sanayi Ve Ticaret Ltd Sirketi Bacillus subtilis bakteri̇ ai̇lesi̇ i̇çeri̇kli̇ bi̇yoteknoloji̇k ürün
KR20250105751A (ko) 2023-12-29 2025-07-09 매일유업 주식회사 모유 올리고당 혼합물 및 프로바이오틱 균주를 유효성분으로 포함하는 신바이오틱 조성물

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110477A (en) 1977-05-13 1978-08-29 Kabushiki Kaisha Naruse Fermentation Laboratory Method for producing natto containing lactic acid bacteria
JP2779963B2 (ja) 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6811786B1 (en) * 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
EP1067945B1 (en) * 1998-04-01 2006-01-04 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
US6942754B2 (en) 1999-03-23 2005-09-13 Oji Paper Co., Ltd. Process for producing xylooligosaccharide from lignocellulose pulp
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1243273A1 (en) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
US20030077255A1 (en) 2001-04-16 2003-04-24 Sabharwal Hemant K. Compositions of bacteria and alpha-lactalbumin and uses thereof
EP1446023B1 (en) 2001-11-12 2009-02-25 Mars, Incorporated Foodstuff for cats and dogs
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
CA2535951A1 (en) * 2003-08-14 2005-03-03 The Bio Balance Corporation Bacterial strains, compositions including same and probiotic use thereof
US7759105B2 (en) 2003-08-29 2010-07-20 Cobb & Company, Llp Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
GB0414655D0 (en) * 2004-06-30 2004-08-04 Leuven K U Res & Dev Prebiotic
RU2395218C2 (ru) 2005-10-24 2010-07-27 Нестек С.А. Композиция пищевых волокон для профилактики или лечения заболеваний пищеварительной системы и композиция пищевых волокон, эффективная при лечении холеры
CN100360658C (zh) * 2006-02-17 2008-01-09 哈尔滨美华生物技术股份有限公司 肠道微生态制剂及其制备方法
CN101095698B (zh) * 2006-06-26 2010-12-01 青岛东海药业有限公司 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
MX2009011696A (es) 2007-05-23 2009-11-10 Tate & Lyle Ingredients Composicion comestible que comprende una composicion de oligosacarido resistente a la digestion o lentamente digestible.
CN101558824B (zh) * 2008-04-15 2011-09-21 北京大北农科技集团股份有限公司 一种复合微生态制剂
US20110318455A1 (en) * 2008-08-04 2011-12-29 Elger Funda Production of beadlets comprising probiotic compounds
CN101744239A (zh) 2008-12-01 2010-06-23 青岛东海药业有限公司 膳食纤维在制备防治便臭或便臭中毒综合征制剂中的应用
CN101449830B (zh) * 2008-12-29 2012-01-11 山东龙力生物科技股份有限公司 一种添加合生元的中老年奶粉及其制备方法
CN101537020B (zh) 2009-04-24 2012-05-02 东北制药集团公司沈阳第一制药厂 地衣芽孢杆菌与寡糖类益生元的合生元及其组合物和制剂
EP2427499A1 (en) * 2009-05-07 2012-03-14 Tate&Lyle Ingredients France SAS Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
US12436408B2 (en) 2022-11-11 2025-10-07 Htc Corporation Wearable device

Similar Documents

Publication Publication Date Title
JP2013537431A5 (enExample)
MX348937B (es) Producto simbiotico.
JP2021527104A5 (enExample)
Vitetta et al. Immunological tolerance and function: associations between intestinal bacteria, probiotics, prebiotics, and phages
Sorini et al. Commensal bacteria-specific CD4+ T cell responses in health and disease
Gasmi et al. The microbiota-mediated dietary and nutritional interventions for COVID-19
Holkem et al. Development and characterization of alginate microcapsules containing Bifidobacterium BB-12 produced by emulsification/internal gelation followed by freeze drying
JP2016537410A5 (enExample)
Cope et al. Novel microbiome-based therapeutics for chronic rhinosinusitis
HRP20180152T1 (hr) Sojevi bakterija koji su izolirani iz svinja
RU2015137415A (ru) Применение штамма htf-f фекальной бактерии prausnitzii htf-f (dsm 26943) для подавления воспаления
NZ601141A (en) Nutritional formulas containing synbiotics
RU2011115228A (ru) Пробиотические продукты для младенцев
PH12016501953A1 (en) Pediatric nutritional composition with human milk oligosaccharides, prebiotics and probiotics
RU2017120146A (ru) Штаммы Lactobacillus или Bifidobacterium для поддержания гомеостаза
RU2018139655A (ru) Бифидобактерии для увеличения безжировой массы тела
RU2011115226A (ru) Пробиотические продукты для младенцев
JP2008520640A5 (enExample)
JP2016529309A5 (enExample)
JP2006273852A5 (enExample)
JP2015525566A5 (enExample)
WO2015018883A3 (en) Probiotic for infantile excessive crying
RU2016122044A (ru) Ферментированное детское питание с неперевариваемыми олигосахаридами
Ngo et al. Microbiota as a potentially-modifiable factor influencing COVID-19
JP2008538288A5 (enExample)